Bypass surgery for chronic stable angina: predictors of survival benefit and strategy for patient selection

Area of Science:

• Cardiology
• Cardiovascular Surgery
• Clinical Decision-Making

Background:

• Chronic stable angina presents variable mortality risks, necessitating careful patient selection for coronary artery bypass grafting (CABG) to prolong life.
• Decades of research have identified key patient characteristics and disease indicators that inform the decision-making process for CABG.
• Understanding these factors is essential for optimizing management strategies aimed at improving patient survival.

Purpose of the Study:

• To identify patient selection variables for coronary artery bypass grafting (CABG) that are associated with improved survival.
• To provide a rational basis for clinical decisions regarding CABG based on evidence from randomized and observational studies.
• To delineate specific patient profiles that are more likely to benefit from CABG in terms of life extension.

Main Methods:

• Review and synthesis of randomized and observational studies conducted over the past 20 years.
• Identification of clinical variables related to coronary artery disease severity, left ventricular function, and angina symptoms.
• Analysis of patient demographics, comorbidity, and electrocardiographic findings in relation to CABG outcomes.

Main Results:

• Patients with worse left ventricular function, more diseased vessels, proximal coronary lesions, severe angina, or provocable ischemia are more likely to benefit from CABG.
• Survival gains are also observed in patients with peripheral vascular disease, specific electrocardiographic changes, and potentially in women.
• Specific criteria, including left main disease, three-vessel disease with dysfunction, and two-vessel disease with proximal LAD involvement, indicate higher likelihood of survival benefit.

Conclusions:

• The decision to perform CABG should be guided by a comprehensive assessment of patient-specific factors and disease characteristics.
• CABG is most beneficial for prolonging life in patients with significant coronary artery disease and impaired cardiac function.
• Factors such as peripheral vascular disease, female sex, and specific ECG changes may favor CABG in borderline cases, while single-vessel disease generally does not confer survival benefit.